ABP
Abpro Corporation
NASDAQ · Healthcare · Biotechnology · US
$0.52
+0.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -0.08x
- Price / sales
- 7.46x
- Price / cash flow
- -0.10x
Enterprise value
- Enterprise value
- $1.7M
- EV / sales
- 9.39x
- EV / EBITDA
- -0.14x
- EV / EBIT
- -0.12x
- Market cap
- $1.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2025